Trimbow(R) is the first triple combination in a single inhaler for the treatment of COPD to receive positive opinion from the CHMP in Europe
May 20, 2017 08:00 ET
|
Chiesi USA, Inc.
PARMA, ITALY--(Marketwired - May 20, 2017) - Chiesi is the first pharmaceutical company to have demonstrated with randomized clinical trials, two of which published in The Lancet 1,2, the efficacy of...
Chiesi USA Makes Two Key Leadership Appointments
May 09, 2017 09:00 ET
|
Chiesi USA, Inc.
CARY, NC--(Marketwired - May 09, 2017) - Today, Chiesi USA announced the appointment of two key leadership roles as the company continues to focus on growth in the U.S. hospital and adjacent...
Chiesi USA, Inc. Earns Triangle Business Journal's 2017 Life Sciences Award -- Company of the Year, Private Division
May 05, 2017 13:00 ET
|
Chiesi USA, Inc.
CARY, NC--(Marketwired - May 05, 2017) - Chiesi USA, a Cary-based specialty pharmaceutical company, today was recognized as Company of the Year, Private Division, during the Triangle Business...
Chiesi USA Sponsors the Triangle March for Babies Walk & 5K Run
April 25, 2017 17:19 ET
|
Chiesi USA, Inc.
CARY, NC--(Marketwired - April 25, 2017) - Chiesi USA is proud to be the signature sponsor of the 2017 Triangle March for Babies Walk & 5K Run. Each year, 15 million babies worldwide are born too...
Glybera Marketing Authorization Application Withdrawn In Europe and Other Selected Countries
April 20, 2017 08:00 ET
|
Chiesi USA, Inc.
PARMA, ITALY--(Marketwired - April 20, 2017) - Chiesi Farmaceutici Spa ("Chiesi") acknowledges that uniQure biopharma B.V (uniQure), have taken the decision to withdraw the ongoing application for...
Chiesi USA, Inc. Earns Triangle Business Journal's Corporate Philanthropy Award
March 24, 2017 08:00 ET
|
Chiesi USA, Inc.
CARY, NC--(Marketwired - March 24, 2017) - Chiesi USA, a Cary-based specialty pharmaceutical company, was recognized this week by the Triangle Business Journal for its corporate philanthropy efforts....
Chiesi USA, Inc. Certified As a 2017 Top Employer in the US
February 13, 2017 08:00 ET
|
Chiesi USA, Inc.
CARY, NC--(Marketwired - February 13, 2017) - Chiesi USA, Inc. announced today that, for the second consecutive year, the company has been named a Top Employer in the United States. The award is...
Digestive Care, Inc. Announces FDA Approval of Infant-Specific Dose of PERTZYE(R) (pancrelipase) Delayed-Release Capsules to Treat Exocrine Pancreatic Insufficiency (EPI) Due to Cystic Fibrosis
October 11, 2016 09:00 ET
|
Digestive Care, Inc.;Chiesi USA, Inc.
BETHLEHEM, PA--(Marketwired - October 11, 2016) - Digestive Care, Inc. (DCI) and its marketing partner in the U.S. cystic fibrosis community, Chiesi USA, Inc., today announced U.S. Food and Drug...
Chiesi USA Supports Durham Bulls' Strike Out Stroke Awareness Initiative
July 07, 2016 15:23 ET
|
Chiesi USA, Inc.
CARY, NC--(Marketwired - July 07, 2016) - Approximately 800,000 Americans suffer a stroke every year, according to the Center for Disease Control. To help individuals understand the warning signs of a...
Chiesi Completes the Acquisition of Three Hospital Products -- Kengreal(R), Cleviprex(R) and Argatroban(TM) for Injection
June 22, 2016 08:00 ET
|
Chiesi USA, Inc.
PARMA, ITALY--(Marketwired - June 22, 2016) - Chiesi USA, Inc. and Chiesi Farmaceutici S.p.A., Chiesi USA's parent company, announced today that the companies have finalized the acquisition of...